Dapagliflozin Raises Breast And Bladder Cancer Risk In Diabetes Patients
Links shared publicly online about this topic.
- 192total visits
Dapagliflozin Raises Breast And Bladder Cancer Risk In Diabetes Patients
View full resource at medicalnewstoday.com
Tags: Diabetes, Diabetes Medication, Cancer, Bladder Cancer, Urinary System, Drug, Women's Health
Most Recently Shared on December 9, 2011 at 9:38 pm By:
#Diabetes dapagliflozin Sustains HbA1c Drop as Add-On http://t.co/Ut3o4kJL NOT worth the risks! http://t.co/Q8umKXt9 #cancer #infections
Also Shared By:
Diabetes Drug Dapagliflozin Rejected by F.D.A. Panel - NYTimes.com
nytimes.com — “In testing, a first-of-its-kind diabetes drug raised safety concerns, including a possible increased risk of breast and bladder cancers.” View full resource at nytimes.com
Most Recently Shared on July 21, 2011 at 11:36 pm By:
NYTimes: Diabetes Drug Dapagliflozin Rejected by F.D.A. Panel http://nyti.ms/pA0N4X
Diabetes Drug Dapagliflozin Rejected by F.D.A. Panel - NYTimes.com
nytimes.com — “In testing, a first-of-its-kind diabetes drug raised safety concerns, including a possible increased risk of breast and bladder cancers.” View full resource at nytimes.com
Most Recently Shared on July 20, 2011 at 5:17 pm By:
McKnight's LTC News Health News and Medical Publisher
Diabetes drug Dapagliflozin rejected by FDA panel; final decision in October. http://t.co/MecrSiX
Diabetes Drug Dapagliflozin Rejected by F.D.A. Panel - QualityPoint Technologies
qualitypointtech.net — “In testing, a first-of-its-kind diabetes drug raised safety concerns, including a possible increased risk of breast and bladder cancers. (Source: NYT Health)MedWorm Message: Register forMedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.” View full resource at qualitypointtech.net
Most Recently Shared on July 20, 2011 at 3:45 am By:
Diabetes Drug Dapagliflozin Rejected by F.D.A. Panel: In testing, a first-of-its-kind diabetes drug raised safety ... http://bit.ly/qYm3gT
Diabetes Drug Dapagliflozin Rejected by F.D.A. Panel - NYTimes.com
nytimes.com — “In testing, a first-of-its-kind diabetes drug raised safety concerns, including a possible increased risk of breast and bladder cancers.” View full resource at nytimes.com
Most Recently Shared on July 20, 2011 at 2:51 am By:
NYT: Diabetes Drug Dapagliflozin Rejected by F.D.A. Panel http://nyti.ms/qraNCK
Diabetes Drug Dapagliflozin Rejected by F.D.A. Panel - NYTimes.com
nytimes.com — “In testing, a first-of-its-kind diabetes drug raised safety concerns, including a possible increased risk of breast and bladder cancers.” View full resource at nytimes.com
Most Recently Shared on July 20, 2011 at 2:46 am By:
Diabetes Drug Dapagliflozin Rejected by F.D.A. Panel http://nyti.ms/n3vtQd
Dapagliflozin Raises Breast And Bladder Cancer Risk In Diabetes Patients - QualityPoint Technologies
qualitypointtech.net — “Experimental diabetes medication - dapagliflozin - was found to raise the risk of developing breast and bladder cancers, researchers reported at the American Diabetes Association meeting, San Diego, California. Drug companies, Bristol-Myers Squibb and Astra Zeneca are studying dapagliflozin as a potential treatment for type 1 and type 2 diabete. Although the drug's method of action can operate on either diabetes type, and even other conditions resulting in hyperglycemia (high blood sugar), the c” View full resource at qualitypointtech.net
Most Recently Shared on June 26, 2011 at 1:45 am By:
Dapagliflozin Raises Breast And Bladder Cancer Risk In Diabetes Patients: Experimental diabetes medication - dapag... http://bit.ly/juW5O1
Advertisement
MNT Health News
@mnt_healthnews
Dapagliflozin Raises Breast And Bladder Cancer Risk In Diabetes Patients http://mnt.to/3XFC #healthnews
1 year ago...